Description | TrkAisamemberoftheneurotrophictyrosinekinasereceptorfamily.Itisamembrane-boundreceptorthatuponneurotrophinbinding,phosphorylatesitselfandmembersoftheMAPKpathway.TrkAisrequiredforhigh-affinitybindingtonervegrowthfactor(NGF),neurotrophin-3andneurotrophin-4/5butnotbrain-derivedneurotrophicfactor(BDNF).TrkAleadstocelldifferentiationsandmayplayaroleinspecifyingsensoryneuronsubtypes.Ithasacrucialroleinthedevelopmentandfunctionofthenociceptivereceptionsystemaswellasestablishmentofthermalregulationviasweating.SUBUNIT:Existsinadynamicequilibriumbetweenmonomeric(lowaffinity)anddimeric(highaffinity)structures.SUBCELLULARLOCATION:Cellmembrane;single-passtypeImembraneprotein.EndocytosedtotheendosomesupontreatmentofcellswithNGF.ALTERNATIVEPRODUCTS:2namedisoformsproducedbyalternativesplicing.BothisoformshavesimilarBIOLOGicalproperties.TISSUESPECIFICITY:IsoformTrkA-IIisprimarilyexpressedinneuronalcells.IsoformTrkA-Iisfoundinnon-neuronaltissues.MutationsinTrkAhavebeenassociatedwithcongenitalinsensitivitytopain,anhidrosis,self-mutalatingbehaviour,mentalretardationandcancer. |
BatchNo. | Seeproductlabel |
Unitsize | 100µg |
Antigen | AsyntheticpeptidecorrespondingtoasequenceinthemiddleregionofhumanTrkA(342-361aa)RHGCLRLNQPTHVNNGNYTL).Thissequenceisidenticaltotherelatedratandmousesequencesaswell. |
Sequence | RHGCLRLNQPTHVNNGNYTL |
AntigenLocation | WithintheIg-likeC2-type2Domainspanningtwoglycosylationsites;epitopelieswithintheextracellularregionoftheprotein(33-423aa)within100aminoacidsofitsentryintothetransmembranedomain(aa424-439)[UniprotP04629(NTRK1_HUMAN) |
AntibodyType | Antiserum |
Isotype | IgG |
OtherNames | Tropomyosin-relatedkinasereceptor,Highaffinitynervegrowthfactorreceptor,Neurotrophictyrosinekinasereceptortype1,TRK1transformingtyrosinekinaseprotein,p140-TrkA,Trk-A,GENENAME:NTRK1,TRK. |
Accession | P04629NTRK1_HUMAN; |
Producedin | Rabbit |
Purity | Affinitypurified |
Applications | WesternBlotting(WB).Aconcentrationof0.1-0.5µg/mlisrecommendedforWB.HumanTrkA(isoformTrkA-II)hasapredictedlengthof796aminoacidsandMWof87kDa.Aconcentrationof0.5-1.0µg/mlisrecommendedtodetecttheproteininformalinfixedandparaffinembeddedtissues.Heatmediatedantigenretrievalisrecommended.Biosensisrecommendsoptimaldilutions/concentrationsshouldbedeterminedbytheenduser. |
Specificity | ThespecificityofthisantibodyhasbeenconfirmedbyWBandIHCagainsttheantigen. |
AntibodyAgainst | TyrosineKinaseReceptorA,TrkA |
Cross-reactivity | Human;rat;predictedtoreactwithmouseduetosequencehomology; |
BlastURL | Clickhere |
Form | Lyophilizedwith5mgBSA,0.9mgNaCl,0.2mgNa2HPO4,0.05mgThimerosal,0.05mgNaN3addedaspreservative |
Appearance | Lyophilizedwhitepowder |
Reconstitution | Reconstitutein100µlofsteriledistilledwatertoachieveanantibodyconcentrationof1mg/ml.Centrifugetoremoveanyinsolublematerial. |
Storage | Atleast12monthsafterpurchaseat2-4°C(lyophilizedformulations).Afterreconstitution,aliquotandstoreat-20°CforahigherstABIlity.Avoidfreeze-thawcycles. |
ExpiryDate | 12monthsafterpurchase |
Biosensis专注于神经科学领域的抗体和试剂的开发,特别是神经营养因子和神经营养因子受体。 近30年来,Biosensis一直是该领域的全球领航者和OEM供应商。除神经营养因子,我们的神经科学产品组合还被广泛用于神经退行性疾病、神经发育和神经代谢的研究。重点研究领域包括阿尔茨海默氏症(AD)、帕金森氏症(PD)和肌萎缩侧索硬化(ALS)疾病,以及自噬和代谢应激障碍,包括肥胖、代谢综合征的研究、神经免疫学和炎症。